Back to results
US 10,647,693 B2Granted
Inhibitors of influenza virus replication, application methods and uses thereof
AssigneeNorth & South Brother Pharmacy Investment Company Limited
InventorsChanghua Tang, Qingyun Ren, Junjun Yin, Kai Yi, Yingjun Zhang
Life of this patent
Estimating the term…
Abstract
The invention provides a novel class of compounds as inhibitors of influenza virus replication, preparation methods thereof, pharmaceutical compositions containing these compounds, and uses of these compounds and pharmaceutical compositions thereof in the manufacture of medicaments for treating of influenza.
Claims19
A compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof,
- wherein
- A is
- wherein U1 is N or CR1;
- U2 is N or CR2;
- U3 is N or CR3;
- U4 is N or CR4;
- each of R1, R2, R3, R4 and R5 is independently H, D, F, Cl, Br, CN, NO2, —C(═O)Ra, —C(═O)ORb, —C(═O)NRcRd, —ORb, —NRcRd, RbO—C1-4 alkylene, RdRcN—C1-4 alkylene, C1-6 alkyl, C2-6 alkenyl or C2-6 alkynyl, and wherein each of C1-6 alkyl, C2-6 alkenyl and C2-6 alkynyl is independently unsubstituted or substituted with 1, 2, 3 or 4 substituents independently selected from D, F, Cl, Br, CN, —ORb, —NRcRd, C1-6 alkyl, C1-6 haloalkyl, RbO—C1-4 alkylene or RdRcN—C1-4 alkylene;
- each of R6 and R8 is independently H, D, F, Cl, Br, CN, NO2, —C(═O)Ra, —C(═O)ORb, —C(═O)NRcRd, —ORb, —NRcRd, RbO—C1-4 alkylene, RdRcN—C1-4 alkylene, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-12 cycloalkyl, C3-12 cycloalkyl-C1-4 alkylene, 3- to 12-membered heterocyclyl, (3- to 12-membered heterocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 10-membered heteroaryl or (5- to 10-membered heteroaryl)-C1-4 alkylene, and wherein each of RbO—C1-4 alkylene, RdRcN—C1-4 alkylene, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-12 cycloalkyl, C3-12 cycloalkyl-C1-4 alkylene, 3- to 12-membered heterocyclyl, (3- to 12-membered heterocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 10-membered heteroaryl and (5- to 10-membered heteroaryl)-C1-4 alkylene is independently unsubstituted or substituted with 1, 2, 3, 4 or 5 R′;
- R7 is —ORg, methyl, C2-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, C3-12 carbocyclyl-C1-4 alkylene, 3- to 12-membered heterocyclyl, (3- to 12-membered heterocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 16-membered heteroaryl or (5- to 16-membered heteroaryl)-C1-4 alkylene, and wherein each of C2-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-12 carbocyclyl, C3-12 carbocyclyl-C1-4 alkylene, 3- to 12-membered heterocyclyl, (3- to 12-membered heterocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 16-membered heteroaryl and (5- to 16-membered heteroaryl)-C1-4 alkylene is independently unsubstituted or substituted with 1, 2, 3, 4 or 5 R′;
- or, R6 and R7, together with the carbon atoms to which they are attached, or R7 and R8, together with the carbon atoms to which they are attached, form a C3-12 carbocyclic ring, 3- to 12-membered heterocyclic ring, C6-10 aromatic ring or 5- to 10-membered heteroaromatic ring, and wherein each of C3-12 carbocyclic ring, 3- to 12-membered heterocyclic ring, C6-10 aromatic ring and 5- to 10-membered heteroaromatic ring is independently unsubstituted or substituted with 1, 2, 3, 4 or 5 R′;
- each R′ is independently D, F, Cl, Br, CN, NO2, —ORb, —NRcRd, RbO—C1-4 alkylene, RdReN—C1-4 alkylene, —C(═O)Ra, —C(═O)ORb, —C(═O)NRcRd, C1-6 alkyl, C1-6 haloalkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-4 alkylene, 3- to 8-membered heterocyclyl, (3- to 8-membered heterocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 8-membered heteroaryl or (5- to 8-membered heteroaryl)-C1-4 alkylene, and wherein each of C1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-4 alkylene, 3- to 8-membered heterocyclyl, (3- to 8-membered heterocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 8-membered heteroaryl and (5- to 8-membered heteroaryl)-C1-4 alkylene is independently unsubstituted or substituted with 1, 2, 3 or 4 substituents independently selected from D, F, Cl, Br, CN, NO2, —ORb, —NRcRd, C1-6 alkyl, C1-6 haloalkyl, RbO—C1-4 alkylene or RdRcN—C1-4 alkylene;
- R9 is H, D or C1-6 alkyl, and wherein C1-6 alkyl is optionally substituted with 1, 2, 3 or 4 substituents independently selected from D, F, Cl, Br, CN, NO2 or —ORb;
- W is C1-8 alkyl, C3-12 carbocyclyl or 3- to 12-membered heterocyclyl, and wherein each of C1-8 alkyl, C3-12 carbocyclyl and 3- to 12-membered heterocyclyl is independently unsubstituted or substituted with 1, 2, 3 or 4 Rw;
- each Rw is independently D, F, Cl, Br, CN, NO2, oxo (═O), —C(═O)Ra, —C(═O)ORb, —C(═O)NRcRh, —NReC(═O)Ra, —NReC(═O)NRcRd, —S(═O)2Rf, —S(═O)2NReC(═O)Ra, —S(═O)2NRcRd, (RbO)2P(═O)—C0-2 alkylene, —ORb, RbO—C1I2 alkylene, C1-6 alkyl, 5- to 6-membered heteroaryl or 5- to 6-membered heterocyclyl, and wherein each of C1-6 alkyl, 5- to 6-membered heteroaryl and 5- to 6-membered heterocyclyl is independently unsubstituted or substituted with 1, 2, 3 or 4 substituents independently selected from D, F, Cl, Br, CN, N3, oxo (═O), NO2, —ORb, C1-6 alkyl or C1-6 haloalkyl;
- each Ra, Rb, Rc, Rd, Re and Rf is independently H, D, C1-6 haloalkyl, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 carbocyclyl, C3-6 carbocyclyl-C1-4 alkylene, 3- to 12-membered heterocyclyl, (3- to 12-membered heterocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 10-membered heteroaryl, (5- to 10-membered heteroaryl)-C1-4 alkylene;
- or, Rc and Rd, together with the nitrogen atom to which they are attached, form 3- to 8-membered heterocyclyl or 5- to 8-membered heteroaryl, and wherein each of C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 carbocyclyl, C3-6 carbocyclyl-C1-4 alkylene, 3- to 12-membered heterocyclyl, (3- to 12-membered heterocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 10-membered heteroaryl, (5- to 10-membered heteroaryl)-C1-4 alkylene, 3- to 8-membered heterocyclyl and 5- to 8-membered heteroaryl is independently unsubstituted or substituted with 1, 2, 3 or 4 substituents independently selected from D, F, Cl, CN, OH, NH2, NO2, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy or C1-6 alkylamino;
- Rg is C1-6 haloalkyl, C2-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 carbocyclyl, C3-6 carbocyclyl-C1-4 alkylene, 3- to 12-membered heterocyclyl, (3- to 12-membered heterocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 10-membered heteroaryl or (5- to 10-membered heteroaryl)-C1-4 alkylene, and wherein each of C2-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 carbocyclyl, C3-6 carbocyclyl-C1-4 alkylene, 3- to 12-membered hereocyclyl, (3- to 12-membered hereocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 10-membered heteroaryl and (5- to 10-membered heteroaryl)-C1-4 alkylene is independently unsubstituted or substituted with 1, 2, 3 or 4 substituents independently selected from D, F, Cl, CN, OH, NH2, NO2, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy or C1-6 alkylamino;
- Rh is C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 carbocyclyl, C3-6 carbocyclyl-C1-4 alkylene, 3- to 12-membered heterocyclyl, (3- to 12-membered heterocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 10-membered heteroaryl, (5- to 10-membered heteroaryl)-C1-4 alkylene;
- or Rc and Rh, together with the nitrogen atom to which they are attached, form a 3- to 8-membered heterocyclyl or 5- to 8-membered heteroaryl, and wherein each of C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 carbocyclyl, C3-6 carbocyclyl-C1-4 alkylene, 3- to 12-membered heterocyclyl, (3- to 12-membered heterocyclyl)-C1-4 alkylene, C6-10 aryl, C6-10 aryl-C1-4 alkylene, 5- to 10-membered heteroaryl, (5- to 10-membered heteroaryl)-C1-4 alkylene, 3- to 8-membered heterocyclyl and 5- to 8-membered heteroaryl is independently unsubstituted or substituted with 1, 2, 3 or 4 substituents independently selected from D, Cl, CN, OH, NH2, NO2, C1-6 alkyl, C1-6 alkoxy or C1-6 alkylamino.
16 more elements
A compound having one of the following structures:
- or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof.
Dependencies are inferred from the claim text.